In this respect, we noticed that 3% of our RA patients with a positive anti-ccp2 test also have a positive anti-cap test (the equivalent test using a cyclic arginine peptide rather than a cyclic citrullinated peptide) (data not shown). This evidence concerns the gene AGBL2 and rheumatoid arthritis.